Samsara BioCapital
Overview
Samsara BioCapital is a venture capital firm founded in 2016 and based in Palo Alto, California . The firm invests in biotechnology companies across the United States, focusing on sectors such as pharmaceuticals, oncology, life sciences, and digital health . Samsara BioCapital aims to support entrepreneurs in the medical field and investment industry, helping them turn their ideas and visions into successful companies . The firm employs a fundamentally-driven approach to life sciences investing, typically taking large, concentrated positions in securities of life sciences companies . Samsara actively engages with the management of its portfolio companies .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Coultreon Biopharma | Apr 2026 | Series A | Co-investor |
| Sidewinder Therapeutics | Apr 2026 | Series B | Co-investor |
| Sidewinder | Apr 2026 | Series B | Co-investor |
| Ambrosia Biosciences Inc. | Mar 2026 | Series B | Co-investor |
| Ambrosia Bio | Mar 2026 | Series B | Co-investor |
Key People
Alan Eisenberg
Venture Partner
Dan Spiegelman
Venture Partner
David Parry
Venture Partner
Dolca Thomas
Venture Partner Senior Advisor
Eric Dobmeier
Venture Partner
Gunaretnam Rajagopal
Venture Partner
James Edwards
Venture Partner, Samsara BioCaptial
John Orwin
Venture Partner
Robert Baffi
Venture Partner
Stephen Shuttleworth
Venture Partner
Cory Freedland
Partner
Abraham Bassan
Principal
Mitchell Mutz
Senior Principal
Matt Eckler
Healthcare Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
